Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen Astellas BioPharma KK

Division of Amgen Inc.
www.amgen.com

Latest From Amgen Astellas BioPharma KK

2017 Preview: Give And Take Marks Mixed Japan, Korea Outlook

As much of Asia celebrates the Lunar New Year holidays, the pharma sector in Japan and South Korea is looking ahead to the Year of the Rooster with a mixture of uncertainty and hope, providing the industry with much to crow about either in support or opposition.

Japan South Korea

2017 Preview: Give And Take Marks Mixed Japan, Korea Outlook

As much of Asia celebrates the Lunar New Year holidays, the pharma sector in Japan and South Korea is looking ahead to the Year of the Rooster with a mixture of uncertainty and hope, providing the industry with much to crow about either in support or opposition.

Japan South Korea

Sanofi Reaches For Post-Plavix Growth In Japan

While Sanofi’s Japanese pharma business is feeling the impact of generic competition to its former blockbuster top product, it is aiming to move back into growth through a string of planned launches over the next few years.

Japan Business Strategies

Oncology Dominates Japan Approvals, Though Overall Tally Is Lower

Although it approved fewer new products last fiscal year, Japan granted access to a number of important new therapies, including in oncology and several for the first time worldwide, helped by continuing reforms at its regulatory body.

Approvals Regulation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Amgen Inc.
  • Senior Management
  • Eiichi Takahashi, General Mgr.
  • Contact Info
  • Amgen Astellas BioPharma KK
    ,
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register